Plasma suPAR is lowered by smoking cessation: a randomized controlled study

suPAR: A New Biomarker for Cardiovascular Disease?

(2015) Gethin W. Hodges et al.   CANADIAN JOURNAL OF CARDIOLOGY

Clinical Evaluation of Multiple Inflammation Biomarkers for Diagnosis and Prognosis for Patients with Systemic Inflammatory Response Syndrome

(2014) M. Reichsoellner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome

(2014) R. B. Raggam et al.   JOURNAL OF INTERNAL MEDICINE

Cigarette Smoking and Variations in Systemic Immune and Inflammation Markers

(2014) Meredith S. Shiels et al.   JNCI-Journal of the National Cancer Institute

Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure

(2014) Alexander Koch et al.   LIVER INTERNATIONAL

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants

(2014) Eva Haastrup et al.   PLoS One

Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events

(2014) Danny J. Eapen et al.   Journal of the American Heart Association

suPAR: The Molecular Crystal Ball

(2013) Maria Thunø et al.   DISEASE MARKERS

Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients

(2013) Katia Donadello et al.   JOURNAL OF CRITICAL CARE

Soluble Urokinase Plasminogen Activator Receptor

(2013) Margaretha Persson et al.   STROKE

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

(2012) Stig Lyngbæk et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

CRP and suPAR are differently related to anthropometry and subclinical organ damage

(2012) Stig Lyngbæk et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals

(2011) A. Langkilde et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

suPAR - a future risk marker

(2011) Jesper Eugen-Olsen   JOURNAL OF INTERNAL MEDICINE

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism

(2010) Lars Tue Sørensen et al.   SURGERY

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling

(2009) Francesco Blasi et al.   FEBS LETTERS